| Literature DB >> 11945120 |
M L López-Rodríguez1, D Ayala, B Benhamú, M J Morcillo, A Viso.
Abstract
Serotonin (5-hydroxytryptamine, 5-HT) is one of the most attractive targets for medicinal chemists. Among 5-HTRs, the 5-HT(1A) subtype is the best studied and it is generally accepted that it is involved in psychiatric disorders such as anxiety and depression. Several structurally different compounds are known to bind 5-HT(1A)R sites. Among these, arylpiperazine derivatives represent one of the most important classes of 5-HT(1A)R ligands. This article will review the development of arylpiperazine derivatives acting at 5-HT(1A)Rs with an emphasis on structure-affinity relationships of agonists and antagonists, ligand-receptor interactions and pharmacological applications.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11945120 DOI: 10.2174/0929867023371030
Source DB: PubMed Journal: Curr Med Chem ISSN: 0929-8673 Impact factor: 4.530